Evidence map›Paper›PMID 31074429›Full record

ArticleJournal of synchrotron radiation2019

The Single Particles, Clusters and Biomolecules and Serial Femtosecond Crystallography instrument of the European XFEL: initial installation.

Adrian P Mancuso, Andrew Aquila, Lewis Batchelor, Richard J Bean, Johan Bielecki, Gannon Borchers, Katerina Doerner, Klaus Giewekemeyer, Rita Graceffa, Oliver D Kelsey and 20 more

Abstract read
In one paragraph

Article in Journal of synchrotron radiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Adrian P MancusoEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Andrew AquilaEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Lewis BatchelorEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Richard J BeanEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Johan BieleckiEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Gannon BorchersEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Katerina DoernerEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Klaus GiewekemeyerEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Rita GraceffaEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Oliver D KelseyEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Yoonhee KimEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Henry J KirkwoodEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Alexis LegrandEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Romain LetrunEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Bradley ManningEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Luis Lopez MorilloEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Marc MesserschmidtEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Grant MillsEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Steffen RaabeEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Nadja ReimersEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Adam RoundEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Tokushi SatoEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Joachim SchulzEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Cedric Signe TakemEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Marcin SikorskiEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Stephan SternEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Prasad ThuteEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Patrik VagovičEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Britta WeinhausenEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.
Thomas TschentscherEuropean XFEL, Holzkoppel 4, 22869 Schenefeld, Germany.

Funding

Australian Research Council Center of Excellence in Advanced Molecular Imaging CE140100011Bundesministerium für Bildung und Forschung 05E13GU1Bundesministerium für Bildung und Forschung 05K13GU7Svenska Forskningsrådet Formas 822-2013-2014Wellcome Trust
6 · The paper itself

Abstract

The European X-ray Free-Electron Laser (FEL) became the first operational high-repetition-rate hard X-ray FEL with first lasing in May 2017. Biological structure determination has already benefitted from the unique properties and capabilities of X-ray FELs, predominantly through the development and application of serial crystallography. The possibility of now performing such experiments at data rates more than an order of magnitude greater than previous X-ray FELs enables not only a higher rate of discovery but also new classes of experiments previously not feasible at lower data rates. One example is time-resolved experiments requiring a higher number of time steps for interpretation, or structure determination from samples with low hit rates in conventional X-ray FEL serial crystallography. Following first lasing at the European XFEL, initial commissioning and operation occurred at two scientific instruments, one of which is the Single Particles, Clusters and Biomolecules and Serial Femtosecond Crystallography (SPB/SFX) instrument. This instrument provides a photon energy range, focal spot sizes and diagnostic tools necessary for structure determination of biological specimens. The instrumentation explicitly addresses serial crystallography and the developing single particle imaging method as well as other forward-scattering and diffraction techniques. This paper describes the major science cases of SPB/SFX and its initial instrumentation - in particular its optical systems, available sample delivery methods, 2D detectors, supporting optical laser systems and key diagnostic components. The present capabilities of the instrument will be reviewed and a brief outlook of its future capabilities is also described.

Indexed as

instrumentationserial crystallographyXFEL

Identifiers

PMID31074429
PMCPMC6510195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.